A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

GL Semenza, GL Wang - Molecular and cellular biology, 1992 - Am Soc Microbiol
GL Semenza, GL Wang
Molecular and cellular biology, 1992Am Soc Microbiol
We have identified a 50-nucleotide enhancer from the human erythropoietin gene 3′-
flanking sequence which can mediate a sevenfold transcriptional induction in response to
hypoxia when cloned 3′ to a simian virus 40 promoter-chloramphenicol acetyltransferase
reporter gene and transiently expressed in Hep3B cells. Nucleotides (nt) 1 to 33 of this
sequence mediate sevenfold induction of reporter gene expression when present in two
tandem copies compared with threefold induction when present in a single copy, suggesting …
Abstract
We have identified a 50-nucleotide enhancer from the human erythropoietin gene 3′-flanking sequence which can mediate a sevenfold transcriptional induction in response to hypoxia when cloned 3′ to a simian virus 40 promoter-chloramphenicol acetyltransferase reporter gene and transiently expressed in Hep3B cells. Nucleotides (nt) 1 to 33 of this sequence mediate sevenfold induction of reporter gene expression when present in two tandem copies compared with threefold induction when present in a single copy, suggesting that nt 34 to 50 bind a factor which amplifies the induction signal. DNase I footprinting demonstrated binding of a constitutive nuclear factor to nt 26 to 48. Mutagenesis studies revealed that nt 4 to 12 and 19 to 23 are essential for induction, as substitutions at either site eliminated hypoxia-induced expression. Electrophoretic mobility shift assays identified a nuclear factor which bound to a probe spanning nt 1 to 18 but not to a probe containing a mutation which eliminated enhancer function. Factor binding was induced by hypoxia, and its induction was sensitive to cycloheximide treatment. We have thus defined a functionally tripartite, 50-nt hypoxia-inducible enhancer which binds several nuclear factors, one of which is induced by hypoxia via de novo protein synthesis.
American Society for Microbiology